文献速递肝胆胰外科围术期管理与 ERAS

教科书式结局:胰腺手术新型质量指标的全国性分析

Textbook Outcome: Nationwide Analysis of a Novel Quality Measure in Pancreatic Surgery.
PubMed 文献 · Ann Surg · 2020-01-01

该研究基于荷兰全国胰腺癌审计2014-2017年数据,纳入3341例胰十二指肠切除术(PD)或远端胰腺切除术(DP)患者,并通过国际专家调查共识定义教科书式结局(TO)。总体60.3%患者达到TO(PD 58.3%,DP 67.4%),TO率在中心间差异显著,提示质量保障项目的潜在价值。

要点

  • TO定义为无术后胰瘘、胆漏、胰腺切除术后出血(均ISGPS B/C级)、严重并发症(Clavien-Dindo≥III)、再入院和院内死亡。
  • PD后ASA 3级预测较差TO率(OR 0.59 [0.44-0.80]),胰管扩张>3mm和PDAC预测较好TO率。
  • DP后女性和无新辅助治疗预测较好TO率,病例组合调整后各医院TO观察值与预期值比值范围为0.71-1.46。

核心结论

  • TO是胰腺手术的新型质量指标,在胰腺中心间差异显著,提示质量保障项目的潜在益处。

研究设计与样本

  • 基于荷兰全国胰腺癌审计2014-2017年前瞻性数据的回顾性分析,纳入3341例PD或DP患者。
  • 通过国际调查(24位专家,10个国家,应答率92%)共识定义TO。

主要发现

  • 总体60.3%患者达到TO,PD为58.3%,DP为67.4%。
  • PD后ASA 3级预测较差TO率(OR 0.59 [0.44-0.80]),胰管扩张>3mm和PDAC预测较好TO率(OR 2.22 [2.05-3.57]和OR 1.36 [1.14-1.63])。
  • DP后女性和无新辅助治疗预测较好TO率(OR 1.38 [1.01-1.90]和OR 2.53 [1.20-5.31])。
  • 病例组合调整后各医院TO观察值与预期值比值范围为0.71-1.46。

关键数值与推荐

  • TO定义为无术后胰瘘、胆漏、胰腺切除术后出血(均ISGPS B/C级)、严重并发症(Clavien-Dindo≥III)、再入院和院内死亡。

临床怎么用

  • TO可作为胰腺手术质量评估的多维度指标,用于比较中心间表现并识别可改进环节。

局限性

  • 研究为回顾性分析,TO定义基于专家共识而非患者报告结局或长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Textbook outcome (TO) is a multidimensional measure for quality assurance, reflecting the "ideal" surgical outcome. METHODS: Post-hoc analysis of patients who underwent pancreatoduodenectomy (PD) or distal pancreatectomy (DP) for all indications between 2014 and 2017, queried from the nationwide prospective Dutch Pancreatic Cancer Audit. An international survey was conducted among 24 experts from 10 countries to reach consensus on the requirements for TO in pancreatic surgery. Univariable and multivariable logistic regression was performed to identify TO predictors. Between-hospital variation in TO rates was compared using observed-versus-expected rates. RESULTS: Based on the survey (92% response rate), TO was defined by the absence of postoperative pancreatic fistula, bile leak, postpancreatectomy hemorrhage (all ISGPS grade B/C), severe complications (Clavien-Dindo ≥III), readmission, and in-hospital mortality. Overall, 3341 patients were included (2633 (79%) PD and 708 (21%) DP) of whom 60.3% achieved TO; 58.3% for PD and 67.4% for DP. On multivariable analysis, ASA class 3 predicted a worse TO rate after PD (ASA 3 OR 0.59 [0.44-0.80]), whereas a dilated pancreatic duct (>3 mm) and pancreatic ductal adenocarcinoma (PDAC) were associated with a better TO rate (OR 2.22 [2.05-3.57] and OR 1.36 [1.14-1.63], respectively). For DP, female sex and the absence of neoadjuvant therapy predicted better TO rates (OR 1.38 [1.01-1.90] and OR 2.53 [1.20-5.31], respectively). When comparing institutions, the observed-versus-expected rate for achieving TO varied from 0.71 to 1.46 per hospital after casemix-adjustment. CONCLUSIONS: TO is a novel quality measure in pancreatic surgery. TO varies considerably between pancreatic centers, demonstrating the potential benefit of quality assurance programs.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. van Roessel S, Mackay TM, van Dieren S, et al. Textbook Outcome: Nationwide Analysis of a Novel Quality Measure in Pancreatic Surgery. Ann Surg. 2020. PMID: 31274651. doi:10.1097/SLA.0000000000003451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。